Skip to Content

  • Search

View Additional Section Content

CALGB 30801 - A Randomized Phase III Double Blind Trial Evaluating Selective COX-2 Inhibition in COX 2 Expressing Advanced Non-Small Cell Lung Cancer.

Clinical Trial Categories

  • Lung Cancer
Contact
The Rosenfeld Cancer Center at 215-481-2402

Location

  • The Rosenfeld Cancer Center

Find a Physician
Search Our Directory

215-481-MEDI

Schedule a Test
Request an Appointment

215-481-EXAM

Clinical Trials Details